Shorts

Christopher Pieczonka, MD, on what’s next for NAI plus BCG in BCG-naïve NMIBC
1:12
Christopher Pieczonka, MD, on what’s next for NAI plus BCG in BCG-naïve NMIBC
3 months ago
by
Christopher Pieczonka, MD
Sara Coca Membribes, MD, on what’s needed to refine the role of BCG-ICI combinations in NMIBC
0:42
Sara Coca Membribes, MD, on what’s needed to refine the role of BCG-ICI combinations in NMIBC
3 months ago
by
Sara Coca Membribes, MD
Jean-Nicolas Cornu, MD, PhD, FEBU, on the patient population of VAPEUR-RCT in BPH
0:45
Jean-Nicolas Cornu, MD, PhD, FEBU, on the patient population of VAPEUR-RCT in BPH
3 months ago
by
Jean-Nicolas Cornu, MD, PhD, FEBU
Antoni Vilaseca Cabo, MD, on the pharmacokinetics of erda-iDRS in NMIBC
0:41
Antoni Vilaseca Cabo, MD, on the pharmacokinetics of erda-iDRS in NMIBC
3 months ago
by
Antoni Vilaseca Cabo, MD
Daniel J. George, MD, on the need for caregiver support in prostate cancer
0:48
Daniel J. George, MD, on the need for caregiver support in prostate cancer
3 months ago
by
Daniel J. George, MD
Brian F. Chapin, MD, on adding local therapy to systemic treatment in metastatic prostate cancer
0:34
Brian F. Chapin, MD, on adding local therapy to systemic treatment in metastatic prostate cancer
3 months ago
by
Brian F. Chapin, MD
Declan Murphy, MB, BCH, on the implications of PRIMARY2 study for prostate cancer diagnosis
0:43
Declan Murphy, MB, BCH, on the implications of PRIMARY2 study for prostate cancer diagnosis
3 months ago
by
Declan Murphy, MB, BCH, BaO, FRACS, FRCS, Urol
Andrea Necchi, MD, on the SURE-02 trial evaluating neoadjuvant sacituzumab govitecan plus pembrolizumab
1:02
Andrea Necchi, MD, on the SURE-02 trial evaluating neoadjuvant sacituzumab govitecan plus pembrolizumab
3 months ago
by
Andrea Necchi, MD
Sam S. Chang, MD, MBA, on the significance of KEYNOTE-B15 data
1:12
Sam S. Chang, MD, MBA, on the significance of KEYNOTE-B15 data
3 months ago
by
Sam S. Chang, MD, MBA
James R. Porter, MD, on the modular architecture of the Hugo RAS
1:08
James R. Porter, MD, on the modular architecture of the Hugo RAS
3 months ago
by
James R. Porter, MD
Maha Hussain, MD, on the significance of BRCAAway data in mCRPC
0:49
Maha Hussain, MD, on the significance of BRCAAway data in mCRPC
3 months ago
by
Maha H. A. Hussain, MD, FASCO, FACP
The Expert APProach: The importance of physician-directed care
1:12
The Expert APProach: The importance of physician-directed care
3 months ago
by
Joy Maulik, CRNP
Mathew D. Sorensen, MD, MS, FACS, on how Break Wave may reduce stent use
0:58
Mathew D. Sorensen, MD, MS, FACS, on how Break Wave may reduce stent use
3 months ago
by
Mathew D. Sorensen, MD, MS
Robert S. Svatek, MD, MSCI, on the global evolution of BCG
1:06
Robert S. Svatek, MD, MSCI, on the global evolution of BCG
3 months ago
by
Robert Svatek, MD
Meri-Margaret Deoudes, CFRE, on bladder cancer diagnosis is often delayed in women
0:48
Meri-Margaret Deoudes, CFRE, on bladder cancer diagnosis is often delayed in women
3 months ago
by
Meri-Margaret Deoudes, CFRE
Pooja Ghatalia, MD, discusses ctDNA’s utility in MIBC
1:08
Pooja Ghatalia, MD, discusses ctDNA’s utility in MIBC
3 months ago
by
Pooja Ghatalia, MD
Stacy Loeb, MD, MSc, PhD (hon), on microplastics in prostate tumors
1:05
Stacy Loeb, MD, MSc, PhD (hon), on microplastics in prostate tumors
3 months ago
by
Stacy Loeb, MD, MSc, PhD (Hon)
Melissa Moran, DO, on prescribing patterns for postmenopausal female HSDD
1:15
Melissa Moran, DO, on prescribing patterns for postmenopausal female HSDD
3 months ago
by
Melissa Moran, DO
Ezra Margolin, MD, on antibiotic use in patients with stones
1:08
Ezra Margolin, MD, on antibiotic use in patients with stones
3 months ago
by
Ezra J. Margolin, MD
Jessica Yih, MD, discusses GLP-1RAs and vulvar health
1:05
Jessica Yih, MD, discusses GLP-1RAs and vulvar health
3 months ago
by
Jessica M. Yih, MD
María Teresa Bourlon, MD, MS, FASCO, on prostate cancer research at ASCO GU 2026
0:55
María Teresa Bourlon, MD, MS, FASCO, on prostate cancer research at ASCO GU 2026
4 months ago
by
María Teresa Bourlon, MD, MS, FASCO
Kiera Liblik, MD, MSc, discusses inconsistent terminology in medical research
0:58
Kiera Liblik, MD, MSc, discusses inconsistent terminology in medical research
4 months ago
by
Kiera Liblik, MD, MSc
Jonathan Yu, MD, on the effect of robotics on vesicourethral anastomotic leaks
0:59
Jonathan Yu, MD, on the effect of robotics on vesicourethral anastomotic leaks
4 months ago
by
Jonathan Yu, MD
Christopher Filson, MD, on exploring bladder cancer biomarkers
1:09
Christopher Filson, MD, on exploring bladder cancer biomarkers
4 months ago
by
Christopher P. Filson, MD, MS
Alex Tatem, MD, outlines the safety of hyaluronic acid penile injections
1:01
Alex Tatem, MD, outlines the safety of hyaluronic acid penile injections
4 months ago
by
Alex Tatem, MD
What are some benefits of multiport robotic partial nephrectomy?
0:55
What are some benefits of multiport robotic partial nephrectomy?
4 months ago
by
Savannah Grandy, DO
The evolution of testicular cancer survivorship care
0:54
The evolution of testicular cancer survivorship care
4 months ago
by
Francisco Ramos, MD
How Break Wave allows for patient participation in kidney stone treatment
1:07
How Break Wave allows for patient participation in kidney stone treatment
4 months ago
by
Mathew D. Sorensen, MD, MS
Christopher Filson, MD, shares data on study of CxBladder Triage
1:15
Christopher Filson, MD, shares data on study of CxBladder Triage
4 months ago
by
Christopher P. Filson, MD, MS
Veda Giri, MD, on patient education for genetic testing
1:22
Veda Giri, MD, on patient education for genetic testing
4 months ago
by
Veda N. Giri, MD